Core Insights - Heidi, a rapidly growing healthcare AI company, has completed a $65 million Series B funding round, led by Point72 Private Investments, with existing investors Blackbird, Headline, and Latitude participating, bringing its valuation to $465 million and total funding to nearly $100 million [1][2] - The funding will accelerate Heidi's mission to create AI healthcare partners that work alongside clinicians, automating tasks such as clinical documentation, evidence retrieval, and follow-up communication, thereby expanding healthcare service capabilities [1][2] - In just 18 months, Heidi has saved frontline clinicians over 18 million hours by streamlining key administrative tasks, addressing the growing demand for healthcare while reducing clinical time [1][2] Company Expansion - As part of the Series B funding, Heidi plans to expand its workforce, office locations, and local support in the U.S., U.K., and Canada, while deepening clinician-led applications in countries like France, Spain, Germany, Ireland, South Africa, Singapore, and Hong Kong [2] - The company has been selected for large-scale AI deployments in the U.K. and has partnered with major healthcare networks in the U.S., Canada, Australia, and New Zealand, indicating a strong international presence [3] Leadership Appointments - Heidi has appointed Paul Williamson as Chief Revenue Officer and Dr. Simon Kos as Chief Medical Officer, both bringing extensive experience from leading companies in their respective fields [2] Company Overview - Heidi focuses on creating AI healthcare partners that automate administrative tasks, allowing clinicians to concentrate on patient care, and supports over 2 million consultations weekly in 116 countries across 110 languages [4] - The company is headquartered in Melbourne, Australia, and has raised a total of $96.6 million from various global investors, adhering to international standards such as NHS, HIPAA, GDPR, and has obtained enterprise-level security certifications [4]